Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology

Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology

Glioblastoma (GBM) is a malignant brain tumor exhibiting rapid and infiltrative growth, with less than 10% of patients surviving over 5 years, despite aggressive and multimodal treatments. The poor prognosis and the lack of effective pharmacological treatments are imputable to a remarkable histologi...

Full description

Bibliographic Details
Main Authors: Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Caterina Tonon, Raffaele Lodi, Raffaele Agati, Stefania Bartolini, Alba Ariela Brandes
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Biomedicines
Subjects:
radiomics
radiogenomics
glioblastoma (GBM)
diffusion weighted MR imaging (DWI)
apparent diffusion coefficient (ADC)
isocitrate dehydrogenase (IDH) mutation
Online Access:https://www.mdpi.com/2227-9059/10/12/3205

Internet

https://www.mdpi.com/2227-9059/10/12/3205

Similar Items